Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.58 USD | +1.05% | -0.85% | -22.36% |
03:30pm | Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise | MT |
05-06 | Rocket Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.36% | 2.12B | |
+2.82% | 108B | |
+10.25% | 104B | |
+2.27% | 22.33B | |
-11.76% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-8.53% | 17.64B | |
+6.25% | 14.05B | |
+35.26% | 12.51B |
- Stock Market
- Equities
- RCKT Stock
- News Rocket Pharmaceuticals, Inc.
- Cantor Fitzgerald Initiates Rocket Pharmaceuticals With Overweight Rating, Price Target is $65